共 50 条
SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth
被引:9
|作者:
Roy, Saumya
[1
]
Axup, Jun Y.
[1
]
Forsyth, Jane S.
[2
]
Goswami, Rajib K.
[1
,3
]
Hutchins, Benjamin M.
[1
]
Bajuri, Krishna M.
[1
]
Kazane, Stephanie A.
[1
,4
]
Smider, Vaughn V.
[1
]
Felding, Brunhilde H.
[2
]
Sinha, Subhash C.
[1
,5
]
机构:
[1] Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem Physiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Indian Assoc Cultivat Sci, Dept Organ Chem, Kolkata, India
[4] Pfizer Inc, Ctr Therapeut Innovat, 10770 Sci Ctr Dr, San Diego, CA 92121 USA
[5] Rockefeller Univ, Lab Mol & Cellular Neurosci, 1230 York Ave, New York, NY 10065 USA
关键词:
INTEGRIN;
IMMUNOTOXINS;
EXPRESSION;
D O I:
10.1039/c7cc00745k
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
Cell-targeting conjugates of Saporin 6, a ribosome inactivating protein (RIP), were prepared using the Saporin Ala 157 Cys mutant, a small molecule inhibitor (SMI) of integrins alpha(v)beta(3)/alpha(v)beta(5), and a potent cytotoxin, auristatin F (AF). The conjugates selectively and potently inhibited proliferation of tumor cells expressing the target integrins. We anticipate that the small molecule-RIP bioconjugate approach can be broadly applied using other small molecule drugs.
引用
收藏
页码:4234 / 4237
页数:4
相关论文